![Cedrik M. Britten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cedrik M. Britten
Directeur Technique/Scientifique/R&D chez
IMMATICS N.V.
Fortune : 2 383 $ au 31/08/2026
Profil
Dr. Cedrik M.
Britten, MD, is a Chief Medical Officer at Immatics Biotechnologies GmbH and a Chief Medical Officer at Immatics NV.
Dr. Britten was previously employed as a VP & Head-Oncology Cell Therapy Research by GlaxoSmithKline Plc and a Vice President-Research & Development by BioNTech RNA Pharmaceuticals GmbH.
He received his graduate degree from The Johannes Gutenberg University of Mainz and a doctorate degree from The Johannes Gutenberg University of Mainz.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 250 ( 0% ) | 2 383 $ | 31/08/2026 |
Postes actifs de Cedrik M. Britten
| Sociétés | Poste | Début |
|---|---|---|
| IMMATICS N.V. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Directeur Technique/Scientifique/R&D | 01/06/2020 |
Anciens postes connus de Cedrik M. Britten
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/05/2020 |
BioNTech RNA Pharmaceuticals GmbH
 BioNTech RNA Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapies to revolutionize the treatment of cancer and other diseases | Directeur Technique/Scientifique/R&D | 01/01/2015 |
Formation de Cedrik M. Britten
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech RNA Pharmaceuticals GmbH
BioNTech RNA Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapies to revolutionize the treatment of cancer and other diseases | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
